BREAKING
Home » Archive by Category "Drugs and antibiotics" (Page 3)
COVID-19

Monoclonal antibody treatment highly effective at reducing COVID-19 hospitalizations

By

By NewsDesk  @bactiman63 Researchers this week published interim results in The New England Journal of Medicine from a Phase 3 study of the COVID-19 monoclonal antibody treatment sotrovimab, sponsored...

Antibiotics: Cubicin recalled due to presence of glass particles

By

NewsDesk @bactiman63 Merck announced voluntarily recalling one lot of CUBICIN® (daptomycin for injection) 500mg for intravenous use, Lot 934778, Exp June 2022. Because treatment with CUBICIN is likely...

Herpes Treatment: Taiwanese and Chinese companies team up to work on long-acting UB-621

By

By NewsDesk  @bactiman63 United BioPharma announced this week that Shanghai Public Health Clinical Centre and Cheng Kung University’s Department of Microbiology and Immunology have joined United...

FDA Approves Expanded Pediatric Indication for HIV Treatment Regimen

By

By NewsDesk  @bactiman63 Gilead Sciences, Inc. today announced the U.S. Food and Drug Administration (FDA) approved a new low-dose tablet dosage form of Biktarvy® (bictegravir 30 mg/emtricitabine 120...

COVID-19

Merck plans to submit for EUA for COVID-19 pill, molnupiravir

By

Merck and Ridgeback Biotherapeutics announced recently that molnupiravir (MK-4482, EIDD-2801), an investigational oral antiviral medicine, significantly reduced the risk of hospitalization or death at...

Cerebral Malaria

Uganda: Artemisinin-resistant malaria detected by Japanese and African researchers

By

By NewsDesk  @infectiousdiseasenews From a press release from Juntendo University in Bunkyo City, Tokyo (computer translated): Malaria is transmitted from person to person through mosquitoes and causes...

Utah health officials: ‘Ivermectin is NOT a COVID-19 drug’

By

By NewsDesk  @infectiousdiseasenews Recently, the Utah Department of Health became aware of a patient who ingested large doses of ivermectin in an attempt to treat symptoms of COVID-19. The patient suffered...

Novartis and Medicines for Malaria Venture report positive results for Phase 2b study of novel ganaplacide/lumefantrine combination in children with malaria

By

NewsDesk  @infectiousdiseasenews As the threat of resistance to current malaria treatment grows, Novartis and MMV have reported positive results of a new non-artemisinin combination in a Phase 2b study. The...

Counties of New Mexico

New Mexico reports two deaths due to ivermectin

By

NewsDesk  @infectiousdiseasenews Last Wednesday, New Mexico state health officials announced during a COVID-19 update the deaths of two people linked to taking the anti-parasitic drug, ivermectin for...

COVID-19

Monoclonal antibody treatment recommended for certain COVID-19 patients: WHO

By

By NewsDesk  @infectiousdiseasenews A treatment combining two antibodies (casirivimab and imdevimab) is recommended for two specific groups of patients with covid-19 by a WHO Guideline Development Group...